Product Development Capabilities American Regent in an excellent position for future growth because of our capabilities in the area of pharmaceutical product development.
Prod_Dev_Icon1 "Turn Key" Product Development Center with capabilities to take a New Chemical Entity (NCE) or a Generic Drug from 'lab bench to patients'
Prod_Dev_Icon2 Robust and diversified pipeline of injectables for future growth encompassing multiple disease indications
Prod_Dev_Icon3 State of the art formulation and analytical laboratories in New Albany, Ohio
Prod_Dev_Icon4 Development capabilities include hormones, controlled substances, cytotoxic molecules, imaging products, antibiotics, nutritional products and complex generics (peptides, microspheres, lipid based nano-carriers drug delivery systems)
Prod_Dev_Icon5 People with a proven track record of fast-tracking both NDAs and ANDAs with innovative regulatory strategies
Prod_Dev_Icon6 Current Good Manufacturing Practice: Manufacturing facilities capable of handling cytotoxic molecules and controlled substances among others (Liquid/lyophilization/Suspensions)


© 2017, American Regent, Inc., A Luitpold Pharmaceuticals, Inc. Company
PP-AS-US-0014     4/2017